Ameriprise’s Annexon ANNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.1M Sell
3,449,121
-899,661
-21% -$5.06M ﹤0.01% 1444
2025
Q4
$21.8M Buy
4,348,782
+2,156,428
+98% +$8.24M ﹤0.01% 1354
2025
Q3
$6.69M Buy
2,192,354
+26,176
+1% +$65K ﹤0.01% 2206
2025
Q2
$5.2M Sell
2,166,178
-1,819,117
-46% -$3.65M ﹤0.01% 2333
2025
Q1
$7.69M Buy
3,985,295
+3,058,653
+330% +$10.2M ﹤0.01% 1963
2024
Q4
$4.75M Buy
926,642
+767,869
+484% +$4.72M ﹤0.01% 2390
2024
Q3
$940K Buy
+158,773
New +$941K ﹤0.01% 3249
2021
Q1
Sell
-247,071
Closed -$6.19M 3833
2020
Q4
$6.19M Buy
247,071
+46,490
+23% +$1.2M ﹤0.01% 2116
2020
Q3
$6.06M Buy
+200,581
New +$4.71M ﹤0.01% 1938

Other funds holding ANNX

Ameriprise's ANNX Position: Q1 2026 in Review

Ameriprise reduced its Annexon (ANNX) stake by 21% in Q1 2026, selling an estimated $5.06M and leaving 3,449,121 shares worth $19.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1444.

Ameriprise first reported a position in ANNX in Q3 2020 and has held it in 9 quarters since. The position peaked at $21.8M in Q4 2025. 217 funds tracked by Wall St. Rank hold ANNX as of Q1 2026.

  • Ameriprise held 3,449,121 shares of Annexon worth $19.1M as of Q1 2026.
  • Ameriprise sold 899,661 Annexon shares in Q1 2026, an estimated $5.06M.
  • Annexon made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1444 holding.
  • Ameriprise first reported a position in Annexon in Q3 2020 and has held it in 9 quarters since.
  • Ameriprise's Annexon position peaked at $21.8M in Q4 2025.
  • 217 funds tracked by Wall St. Rank held Annexon as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.